Company profile
CORCEPT THERAPEUTICS INC insider acquisitions
Company CIK 0001088856 · Reported insider acquisitions and filing context.
These are company listings. A transaction is linked to a particular security only when the filing provides enough information.
Company activity summary
By transaction date, as of October 21, 2026.
| Type / code | Reported security | Transactions | Known purchase value | Missing amounts |
|---|---|---|---|---|
| Stock awardCode A | Stock Option (right to buy)Derivative · Currency not specified | 1 | Not applicable | 0 |
| Exercise / conversionCode M | Common StockNon-derivative · Currency not specified | 6 | Not applicable | 0 |
Known purchase value sums available amounts for non-derivative purchases only. Missing amounts are excluded. “Currency not specified” does not establish that the amounts share a currency. These summaries use all matching loaded records, while the timeline below covers only the current page.
Transaction timeline
Who reported an acquisition, and when the transaction occurred.
30 dated transactions · 8 of 10 reporting owners shown. Select one owner to focus the chart.
View timeline as a table
| Transaction date | Company / security | Reporting owners | Acquisition type |
|---|---|---|---|
| Oct 2, 2026 | CORCEPT THERAPEUTICS INCCommon Stock | Vieira Roberto Wandenkolk | Exercise / conversion |
| Oct 2, 2026 | CORCEPT THERAPEUTICS INCCommon Stock | Lyon Joseph Douglas | Exercise / conversion |
| Oct 2, 2026 | CORCEPT THERAPEUTICS INCCommon Stock | Lyon Joseph Douglas | Exercise / conversion |
| Oct 1, 2026 | CORCEPT THERAPEUTICS INCCommon Stock | Lyon Joseph Douglas | Exercise / conversion |
| Oct 2, 2026 | CORCEPT THERAPEUTICS INCCommon Stock | Maduck Sean | Exercise / conversion |
| Oct 1, 2026 | CORCEPT THERAPEUTICS INCCommon Stock | Maduck Sean | Exercise / conversion |
| Oct 1, 2026 | CORCEPT THERAPEUTICS INCStock Option (right to buy) | Gunn Justin Frederick | Stock award |
| Dec 24, 2025 | CORCEPT THERAPEUTICS INCCommon Stock | Robb Gary Charles | Exercise / conversion |
| Dec 24, 2025 | CORCEPT THERAPEUTICS INCCommon Stock | BELANOFF JOSEPH K | Other acquisition |
| Dec 24, 2025 | CORCEPT THERAPEUTICS INCCommon Stock | BELANOFF JOSEPH K | Exercise / conversion |
| Dec 12, 2025 | CORCEPT THERAPEUTICS INCCommon Stock | WILSON JAMES N | Other acquisition |
| Dec 12, 2025 | CORCEPT THERAPEUTICS INCCommon Stock | WILSON JAMES N | Other acquisition |
| Dec 2, 2025 | CORCEPT THERAPEUTICS INCCommon Stock | Guyer William | Exercise / conversion |
| Dec 2, 2025 | CORCEPT THERAPEUTICS INCCommon Stock | Guyer William | Other acquisition |
| Dec 1, 2025 | CORCEPT THERAPEUTICS INCCommon Stock | Guyer William | Stock award |
| Dec 1, 2025 | CORCEPT THERAPEUTICS INCCommon Stock | Guyer William | Stock award |
| Dec 1, 2025 | CORCEPT THERAPEUTICS INCCommon Stock | Maduck Sean | Stock award |
| Dec 1, 2025 | CORCEPT THERAPEUTICS INCCommon Stock | Maduck Sean | Stock award |
| Dec 1, 2025 | CORCEPT THERAPEUTICS INCCommon Stock | Maduck Sean | Exercise / conversion |
| Dec 1, 2025 | CORCEPT THERAPEUTICS INCCommon Stock | Lyon Joseph Douglas | Stock award |
| Dec 1, 2025 | CORCEPT THERAPEUTICS INCCommon Stock | Lyon Joseph Douglas | Stock award |
| Dec 1, 2025 | CORCEPT THERAPEUTICS INCCommon Stock | Lyon Joseph Douglas | Exercise / conversion |
| Dec 1, 2025 | CORCEPT THERAPEUTICS INCCommon Stock | Mokari Atabak | Stock award |
| Dec 1, 2025 | CORCEPT THERAPEUTICS INCCommon Stock | Mokari Atabak | Stock award |
| Dec 1, 2025 | CORCEPT THERAPEUTICS INCCommon Stock | Robb Gary Charles | Stock award |
| Dec 1, 2025 | CORCEPT THERAPEUTICS INCCommon Stock | Robb Gary Charles | Stock award |
| Nov 5, 2025 | CORCEPT THERAPEUTICS INCCommon Stock | Guyer William | Exercise / conversion |
| Nov 3, 2025 | CORCEPT THERAPEUTICS INCCommon Stock | Lyon Joseph Douglas | Exercise / conversion |
| Nov 3, 2025 | CORCEPT THERAPEUTICS INCCommon Stock | Maduck Sean | Exercise / conversion |
| Oct 10, 2025 | CORCEPT THERAPEUTICS INCCommon Stock | Swisher Daniel N JR | Exercise / conversion |
Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.
Share price & reported acquisitions
Daily closing prices from a separate source. The date window above also filters prices; reporting-owner and transaction-type selections filter the markers.
Price history is not available
Market-price history is not connected yet.
CORT · Currency not specified. A marker uses that day's closing price, not the reported transaction price. No price is substituted for a missing trading day.
Reported acquisitions
Filing-date filters apply to the list and timeline. The summary above uses transaction dates.
| Filed / transacted | Reporting owners | Type / security | Quantity | Price / reference value | Details |
|---|---|---|---|---|---|
| Trade: | Vieira Roberto WandenkolkPresident, Oncology | Exercise / conversionCommon StockNon-derivative security · Code M | 8,333 | 21.63Value: 180,242.79Currency not specified | View ↗ |
| Trade: | Lyon Joseph DouglasSee Remarks | Exercise / conversionCommon StockNon-derivative security · Code M | 5,833 | 19.26Value: 112,343.58Currency not specified | View ↗ |
| Trade: | Lyon Joseph DouglasSee Remarks | Exercise / conversionCommon StockNon-derivative security · Code M | 3,357 | 13.56Value: 45,520.92Currency not specified | View ↗ |
| Trade: | Lyon Joseph DouglasSee Remarks | Exercise / conversionCommon StockNon-derivative security · Code M | 810 | 13.56Value: 10,983.6Currency not specified | View ↗ |
| Trade: | Maduck SeanSee Remarks | Exercise / conversionCommon StockNon-derivative security · Code M | 24,587 | 8.27Value: 203,334.49Currency not specified | View ↗ |
| Trade: | Maduck SeanSee Remarks | Exercise / conversionCommon StockNon-derivative security · Code M | 413 | 8.27Value: 3,415.51Currency not specified | View ↗ |
| Trade: | Gunn Justin FrederickSee Remarks | Stock awardStock Option (right to buy)Derivative security · Code A | 100,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Robb Gary CharlesChief Business Officer | Exercise / conversionCommon StockNon-derivative security · Code M | 145,000 | 3.88Value: 562,600Currency not specified | View ↗ |
| Trade: | BELANOFF JOSEPH KChief Executive Officer · Director | Other acquisitionCommon StockNon-derivative security · Code J | 243,154 | 0Value: 0Currency not specified | View ↗ |
| Trade: | BELANOFF JOSEPH KChief Executive Officer · Director | Exercise / conversionCommon StockNon-derivative security · Code M | 550,000 | 3.88Value: 2,134,000Currency not specified | View ↗ |
| Trade: | WILSON JAMES NDirector | Other acquisitionCommon StockNon-derivative security · Code J | 200,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | WILSON JAMES NDirector | Other acquisitionCommon StockNon-derivative security · Code J | 200,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Guyer WilliamChief Development Officer | Exercise / conversionCommon StockNon-derivative security · Code M | 20,000 | 21.65Value: 433,000Currency not specified | View ↗ |
| Trade: | Guyer WilliamChief Development Officer | Other acquisitionCommon StockNon-derivative security · Code J | 787 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Guyer WilliamChief Development Officer | Stock awardCommon StockNon-derivative security · Code A | 224 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Guyer WilliamChief Development Officer | Stock awardCommon StockNon-derivative security · Code A | 224 | 79.78 *Value: 17,870.72Currency not specified | View ↗ |
| Trade: | Maduck SeanSee Remarks | Stock awardCommon StockNon-derivative security · Code A | 205 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Maduck SeanSee Remarks | Stock awardCommon StockNon-derivative security · Code A | 205 | 79.78 *Value: 16,354.9Currency not specified | View ↗ |
| Trade: | Maduck SeanSee Remarks | Exercise / conversionCommon StockNon-derivative security · Code M | 20,000 | 8.27Value: 165,400Currency not specified | View ↗ |
| Trade: | Lyon Joseph DouglasSee Remarks | Stock awardCommon StockNon-derivative security · Code A | 178 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Lyon Joseph DouglasSee Remarks | Stock awardCommon StockNon-derivative security · Code A | 178 | 79.78 *Value: 14,200.84Currency not specified | View ↗ |
| Trade: | Lyon Joseph DouglasSee Remarks | Exercise / conversionCommon StockNon-derivative security · Code M | 5,000 | 13.56Value: 67,800Currency not specified | View ↗ |
| Trade: | Mokari AtabakChief Financial Officer | Stock awardCommon StockNon-derivative security · Code A | 178 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Mokari AtabakChief Financial Officer | Stock awardCommon StockNon-derivative security · Code A | 178 | 79.78 *Value: 14,200.84Currency not specified | View ↗ |
| Trade: | Robb Gary CharlesChief Business Officer | Stock awardCommon StockNon-derivative security · Code A | 224 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Robb Gary CharlesChief Business Officer | Stock awardCommon StockNon-derivative security · Code A | 224 | 79.78 *Value: 17,870.72Currency not specified | View ↗ |
| Trade: | Guyer WilliamChief Development Officer | Exercise / conversionCommon StockNon-derivative security · Code M | 20,000 | 21.65Value: 433,000Currency not specified | View ↗ |
| Trade: | Lyon Joseph DouglasSee Remarks | Exercise / conversionCommon StockNon-derivative security · Code M | 5,000 | 13.56Value: 67,800Currency not specified | View ↗ |
| Trade: | Maduck SeanSee Remarks | Exercise / conversionCommon StockNon-derivative security · Code M | 20,000 | 8.27Value: 165,400Currency not specified | View ↗ |
| Trade: | Swisher Daniel N JRDirector | Exercise / conversionCommon StockNon-derivative security · Code M | 2,200 | 14.08Value: 30,976Currency not specified | View ↗ |
30 transactions on this page. Filing date, newest first.
Reporting owners are associated with a filing. Jointly reported amounts are not allocated to individual owners. Historical coverage is still being built. Read the methodology →